XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.2
Organization and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Summary of Financial Instruments Measured at Fair Value on Recurring Basis

The following tables summarize the Company’s financial instruments measured at fair value on a recurring basis (in thousands):

 

 

 

 

 

 

Fair Value Measurements at
Reporting Date Using

 

 

 

Total

 

 

Quoted Prices in
Active Markets for
Identical Assets
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

As of June 30, 2022:

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

34,229

 

 

$

34,229

 

 

$

 

 

$

 

Total cash equivalents

 

 

34,229

 

 

 

34,229

 

 

 

 

 

 

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

122,883

 

 

 

122,883

 

 

 

 

 

 

 

U.S. agency bonds

 

 

23,404

 

 

 

 

 

 

23,404

 

 

 

 

Commercial paper

 

 

149,606

 

 

 

 

 

 

149,606

 

 

 

 

Total short-term investments

 

 

295,893

 

 

 

122,883

 

 

 

173,010

 

 

 

 

Restricted cash:

 

 

 

 

 

 

 

 

 

 

 

 

Money market account

 

 

816

 

 

 

816

 

 

 

 

 

 

 

Total restricted cash

 

 

816

 

 

 

816

 

 

 

 

 

 

 

Total assets measured at fair value on a recurring basis

 

$

330,938

 

 

$

157,928

 

 

$

173,010

 

 

$

 

 

 

 

 

 

 

 

Fair Value Measurements at
Reporting Date Using

 

 

 

Total

 

 

Quoted Prices in
Active Markets for
Identical Assets
(Level 1)

 

 

Significant Other
Observable Inputs
(Level 2)

 

 

Significant
Unobservable
Inputs
(Level 3)

 

As of December 31, 2021:

 

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

15,020

 

 

$

15,020

 

 

$

 

 

$

 

Commercial paper

 

 

9,998

 

 

 

 

 

 

9,998

 

 

 

 

Total cash equivalents

 

 

25,018

 

 

 

15,020

 

 

 

9,998

 

 

 

 

Short-term investments:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

99,247

 

 

 

99,247

 

 

 

 

 

 

 

Corporate debt securities

 

 

6,026

 

 

 

 

 

 

6,026

 

 

 

 

Commercial paper

 

 

234,110

 

 

 

 

 

 

234,110

 

 

 

 

Total short-term investments

 

 

339,383

 

 

 

99,247

 

 

 

240,136

 

 

 

 

Restricted cash:

 

 

 

 

 

 

 

 

 

 

 

 

Money market account

 

 

816

 

 

 

816

 

 

 

 

 

 

 

Total restricted cash

 

 

816

 

 

 

816

 

 

 

 

 

 

 

Total assets measured at fair value on a recurring basis

 

$

365,217

 

 

$

115,083

 

 

$

250,134

 

 

$

 

Reconciliation of Cash and Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the accompanying balance sheets that sum to the amounts shown in the statements of cash flows (in thousands):

 

 

June 30,
2022

 

 

December 31,
2021

 

 Cash and cash equivalents

 

$

58,403

 

 

$

35,582

 

 Restricted cash

 

 

816

 

 

 

816

 

 Total cash and cash equivalents and restricted cash

 

$

59,219

 

 

$

36,398

 

Summary of Short-Term Investments

The following tables summarize short-term investments (in thousands):

 

 

 

As of June 30, 2022

 

 

 

Amortized

 

 

Unrealized

 

 

Estimated

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

U.S. Treasury securities

 

$

124,418

 

 

$

 

 

$

(1,535

)

 

$

122,883

 

U.S. agency bonds

 

 

23,499

 

 

 

 

 

 

(95

)

 

 

23,404

 

Commercial paper

 

 

149,883

 

 

 

15

 

 

 

(292

)

 

 

149,606

 

Total

 

$

297,800

 

 

$

15

 

 

$

(1,922

)

 

$

295,893

 

 

 

 

As of December 31, 2021

 

 

 

Amortized

 

 

Unrealized

 

 

Estimated

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Fair Value

 

U.S. Treasury securities

 

$

99,457

 

 

$

 

 

$

(210

)

 

$

99,247

 

Corporate debt securities

 

 

6,029

 

 

 

 

 

 

(3

)

 

 

6,026

 

Commercial paper

 

 

234,167

 

 

 

7

 

 

 

(64

)

 

 

234,110

 

Total

 

$

339,653

 

 

$

7

 

 

$

(277

)

 

$

339,383

 

Schedule of Contractual Maturities of Available-for-sale Debt Securities

Contractual maturities of available-for-sale debt securities are as follows (in thousands):

 

 

 

As of June 30, 2022

 

 

 

Due in 1 Year or Less

 

 

Due Between 1 and 2 Years

 

 U.S. Treasury securities

 

$

122,883

 

 

$

 

 U.S. agency bonds

 

 

18,414

 

 

 

4,990

 

 Commercial paper

 

 

149,606

 

 

 

 

 Total

 

$

290,903

 

 

$

4,990

 

 

 

 

As of December 31, 2021

 

 

 

Due in 1 Year or Less

 

 

Due Between 1 and 2 Years

 

 U.S. Treasury securities

 

$

51,131

 

 

$

48,116

 

 Corporate debt securities

 

 

6,026

 

 

 

 

 Commercial paper

 

 

234,110

 

 

 

 

 Total

 

$

291,267

 

 

$

48,116

 

Summary of Potentially Dilutive Shares Not Included in the Calculation of Net Loss Per Share

Potentially dilutive securities not included in the calculation of diluted net loss per share, because to do so would be anti-dilutive, are as follows (in common stock equivalent shares):

 

 

 

June 30,

 

 

 

2022

 

 

2021

 

Common stock options

 

 

7,548,970

 

 

 

5,173,702

 

Unvested common stock

 

 

161,760

 

 

 

516,951

 

Employee stock purchase plan shares

 

 

5,936

 

 

 

1,235

 

Total potentially dilutive shares

 

 

7,716,666

 

 

 

5,691,888